NCT06208657 2026-01-28
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Australian & New Zealand Children's Haematology/Oncology Group
Phase 1/2 Recruiting
Australian & New Zealand Children's Haematology/Oncology Group
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
National Institutes of Health Clinical Center (CC)
Amgen
Merck KGaA, Darmstadt, Germany
University Hospital, Clermont-Ferrand
New York Prostate Institute